Vaxcyte, Inc. (PCVX)
71.38
+6.36
(+9.79%)
USD |
NASDAQ |
Oct 09, 16:00
71.38
0.00 (0.00%)
After-Hours: 04:05
Vaxcyte Price to Book Value : 3.747 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 3.747 |
| October 08, 2026 | 3.413 |
| October 07, 2026 | 3.515 |
| October 06, 2026 | 3.502 |
| October 05, 2026 | 3.875 |
| October 02, 2026 | 2.965 |
| October 01, 2026 | 2.942 |
| September 30, 2026 | 2.987 |
| September 29, 2026 | 2.976 |
| September 28, 2026 | 3.059 |
| September 25, 2026 | 2.951 |
| September 24, 2026 | 2.987 |
| September 23, 2026 | 2.966 |
| September 22, 2026 | 3.098 |
| September 21, 2026 | 3.093 |
| September 18, 2026 | 3.052 |
| September 17, 2026 | 3.169 |
| September 16, 2026 | 3.085 |
| September 15, 2026 | 3.108 |
| September 14, 2026 | 3.126 |
| September 11, 2026 | 3.122 |
| September 10, 2026 | 3.092 |
| September 09, 2026 | 3.124 |
| September 08, 2026 | 3.169 |
| September 04, 2026 | 3.211 |
| Date | Value |
|---|---|
| September 03, 2026 | 3.211 |
| September 02, 2026 | 3.233 |
| September 01, 2026 | 3.192 |
| August 31, 2026 | 3.189 |
| August 28, 2026 | 3.141 |
| August 27, 2026 | 3.210 |
| August 26, 2026 | 3.207 |
| August 25, 2026 | 3.207 |
| August 24, 2026 | 3.248 |
| August 21, 2026 | 3.287 |
| August 20, 2026 | 3.220 |
| August 19, 2026 | 3.323 |
| August 18, 2026 | 3.139 |
| August 17, 2026 | 3.161 |
| August 14, 2026 | 3.048 |
| August 13, 2026 | 3.09 |
| August 12, 2026 | 3.132 |
| August 11, 2026 | 3.109 |
| August 10, 2026 | 3.060 |
| August 07, 2026 | 3.048 |
| August 06, 2026 | 3.092 |
| August 05, 2026 | 2.936 |
| August 04, 2026 | 2.871 |
| August 03, 2026 | 2.810 |
| July 31, 2026 | 2.839 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 13.28 |
| Vir Biotechnology, Inc. | 2.015 |
| Revolution Medicines, Inc. | 15.60 |
| Arrowhead Pharmaceuticals, Inc. | 19.02 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.1104 |
| Price | 71.38 |
| Earnings Yield | -10.80% |
| Market Cap | 10.33B |
| PEGY Ratio | -0.1104 |